Talk:Triple releasing agent: Difference between revisions

Line 1:

'''Triple releasing agent''' (also called a '''TRA''' or '''triple releaser''') is a informal term to describe a type of psychoactive substance which ~~induces~~ the release and increase in concentration of the three major central nervous [[monoamine]] neurotransmitters, [[serotonin]], [[norepinephrine]], and [[dopamine]] in the brain. In the field of neuropharmacology, they are more formally referred to as '''serotonin-norepinephrine-dopamine releasing agents (SNDRA)'''.

'''Triple releasing agent''' (also called a '''TRA''' or '''triple releaser''') is a informal term to describe a type of psychoactive substance which exerts its activity by inducing the release and increase in concentration of the three major central nervous [[monoamine]] neurotransmitters, [[serotonin]], [[norepinephrine]], and [[dopamine]] within the [[synapse]]s of various regions in the brain. In the field of neuropharmacology, they are more formally referred to as '''serotonin-norepinephrine-dopamine releasing agents (SNDRA)'''.{{citation needed}}

In the context of [[psychonautics]] and [[recreational drug use]] triple releasing agents are typically associated with the ability to produce [[Euphoria|euphoriant]], [[entactogen]]ic, and [[stimulant|stimulating]] effects in a manner similar to [[MDMA]], [[MDA]], [[4-FA]] and other amphetamine-based compounds, with the entactogenic aspects being the most prominent.

Revision as of 03:00, 12 April 2017 view source >Unity attempt at merge ← Older edit		Revision as of 03:03, 12 April 2017 view source >Unity citation, grammatics Newer edit →
Line 1:		Line 1:
	'''Triple releasing agent''' (also called a '''TRA''' or '''triple releaser''') is a informal term to describe a type of psychoactive substance which ~~induces~~ the release and increase in concentration of the three major central nervous [[monoamine]] neurotransmitters, [[serotonin]], [[norepinephrine]], and [[dopamine]] in the brain. In the field of neuropharmacology, they are more formally referred to as '''serotonin-norepinephrine-dopamine releasing agents (SNDRA)'''.		'''Triple releasing agent''' (also called a '''TRA''' or '''triple releaser''') is a informal term to describe a type of psychoactive substance which exerts its activity by inducing the release and increase in concentration of the three major central nervous [[monoamine]] neurotransmitters, [[serotonin]], [[norepinephrine]], and [[dopamine]] within the [[synapse]]s of various regions in the brain. In the field of neuropharmacology, they are more formally referred to as '''serotonin-norepinephrine-dopamine releasing agents (SNDRA)'''.{{citation needed}}

	In the context of [[psychonautics]] and [[recreational drug use]] triple releasing agents are typically associated with the ability to produce [[Euphoria\|euphoriant]], [[entactogen]]ic, and [[stimulant\|stimulating]] effects in a manner similar to [[MDMA]], [[MDA]], [[4-FA]] and other amphetamine-based compounds, with the entactogenic aspects being the most prominent.		In the context of [[psychonautics]] and [[recreational drug use]] triple releasing agents are typically associated with the ability to produce [[Euphoria\|euphoriant]], [[entactogen]]ic, and [[stimulant\|stimulating]] effects in a manner similar to [[MDMA]], [[MDA]], [[4-FA]] and other amphetamine-based compounds, with the entactogenic aspects being the most prominent.